APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Vaccine

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Selected research

Market Analysis & Forecast

Global Veterinary Vaccine Market Analysis and Forecast 2026-2032

9 January 2026211 pages

Choose your research edition.

Industry ResearchVeterinary Vaccine Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Vaccine Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Veterinary Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Vaccine Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Vaccine Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.

This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.

Veterinary Vaccine Segment by Company

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

MEVAC

Biovac

Atafen

Dyntec

BioTestLab

RVSRI

Medion

Veterinary Vaccine Segment by Type

Live Attenuated Vaccines

Inactivated Vaccines

Others

Veterinary Vaccine Segment by Application

Livestock

Swine

Chicken

Dog & Cat

Others

Veterinary Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Veterinary Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Attenuated Vaccines Major Manufacturers Table 3. Inactivated Vaccines Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Veterinary Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Livestock Major Manufacturers Table 7. Swine Major Manufacturers Table 8. Chicken Major Manufacturers Table 9. Dog & Cat Major Manufacturers Table 10. Others Major Manufacturers Table 11. Veterinary Vaccine Industry Trends Table 12. Veterinary Vaccine Industry Drivers Table 13. Veterinary Vaccine Industry Opportunities and Challenges Table 14. Veterinary Vaccine Industry Restraints Table 15. Global Veterinary Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Veterinary Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Veterinary Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Veterinary Vaccine Revenue Market Share by Region (2021-2026) Table 19. Global Veterinary Vaccine Revenue Market Share by Region (2027-2032) Table 20. Global Veterinary Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 21. Global Veterinary Vaccine Sales by Region (2021-2026) & (M Doses) Table 22. Global Veterinary Vaccine Sales by Region (2027-2032) & (M Doses) Table 23. Global Veterinary Vaccine Sales Market Share by Region (2021-2026) Table 24. Global Veterinary Vaccine Sales Market Share by Region (2027-2032) Table 25. Global Veterinary Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Veterinary Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Veterinary Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Veterinary Vaccine Sales Market Share by Manufacturers (2021-2026) Table 29. Global Veterinary Vaccine Sales Price (USD/Doses) of Manufacturers (2021-2026) Table 30. Global Veterinary Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Veterinary Vaccine Manufacturers, Product Type & Application Table 33. Global Veterinary Vaccine Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Veterinary Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Veterinary Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Veterinary Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Veterinary Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Veterinary Vaccine Revenue Market Share by Type (2021-2026) Table 40. Global Veterinary Vaccine Revenue Market Share by Type (2027-2032) Table 41. Global Veterinary Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 42. Global Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 43. Global Veterinary Vaccine Sales by Type (2027-2032) & (M Doses) Table 44. Global Veterinary Vaccine Sales Market Share by Type (2021-2026) Table 45. Global Veterinary Vaccine Sales Market Share by Type (2027-2032) Table 46. Global Veterinary Vaccine Price by Type (2021-2026) & (USD/Doses) Table 47. Global Veterinary Vaccine Price by Type (2027-2032) & (USD/Doses) Table 48. Global Veterinary Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Veterinary Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Veterinary Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Veterinary Vaccine Revenue Market Share by Application (2021-2026) Table 52. Global Veterinary Vaccine Revenue Market Share by Application (2027-2032) Table 53. Global Veterinary Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 54. Global Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 55. Global Veterinary Vaccine Sales by Application (2027-2032) & (M Doses) Table 56. Global Veterinary Vaccine Sales Market Share by Application (2021-2026) Table 57. Global Veterinary Vaccine Sales Market Share by Application (2027-2032) Table 58. Global Veterinary Vaccine Price by Application (2021-2026) & (USD/Doses) Table 59. Global Veterinary Vaccine Price by Application (2027-2032) & (USD/Doses) Table 60. Merck Company Information Table 61. Merck Business Overview Table 62. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 63. Merck Veterinary Vaccine Product Portfolio Table 64. Merck Recent Development Table 65. Zoetis Company Information Table 66. Zoetis Business Overview Table 67. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 68. Zoetis Veterinary Vaccine Product Portfolio Table 69. Zoetis Recent Development Table 70. Boehringer Ingelheim Company Information Table 71. Boehringer Ingelheim Business Overview Table 72. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 73. Boehringer Ingelheim Veterinary Vaccine Product Portfolio Table 74. Boehringer Ingelheim Recent Development Table 75. Ceva Company Information Table 76. Ceva Business Overview Table 77. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 78. Ceva Veterinary Vaccine Product Portfolio Table 79. Ceva Recent Development Table 80. CAHIC Company Information Table 81. CAHIC Business Overview Table 82. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 83. CAHIC Veterinary Vaccine Product Portfolio Table 84. CAHIC Recent Development Table 85. HVRI Company Information Table 86. HVRI Business Overview Table 87. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 88. HVRI Veterinary Vaccine Product Portfolio Table 89. HVRI Recent Development Table 90. Ringpu Biology Company Information Table 91. Ringpu Biology Business Overview Table 92. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 93. Ringpu Biology Veterinary Vaccine Product Portfolio Table 94. Ringpu Biology Recent Development Table 95. Yebio Company Information Table 96. Yebio Business Overview Table 97. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 98. Yebio Veterinary Vaccine Product Portfolio Table 99. Yebio Recent Development Table 100. DHN Company Information Table 101. DHN Business Overview Table 102. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 103. DHN Veterinary Vaccine Product Portfolio Table 104. DHN Recent Development Table 105. WINSUN Company Information Table 106. WINSUN Business Overview Table 107. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 108. WINSUN Veterinary Vaccine Product Portfolio Table 109. WINSUN Recent Development Table 110. Elanco Company Information Table 111. Elanco Business Overview Table 112. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 113. Elanco Veterinary Vaccine Product Portfolio Table 114. Elanco Recent Development Table 115. Virbac Company Information Table 116. Virbac Business Overview Table 117. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 118. Virbac Veterinary Vaccine Product Portfolio Table 119. Virbac Recent Development Table 120. Jinyu Bio-Technology Company Information Table 121. Jinyu Bio-Technology Business Overview Table 122. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 123. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio Table 124. Jinyu Bio-Technology Recent Development Table 125. ChengDu Tecbond Company Information Table 126. ChengDu Tecbond Business Overview Table 127. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 128. ChengDu Tecbond Veterinary Vaccine Product Portfolio Table 129. ChengDu Tecbond Recent Development Table 130. CAVAC Company Information Table 131. CAVAC Business Overview Table 132. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 133. CAVAC Veterinary Vaccine Product Portfolio Table 134. CAVAC Recent Development Table 135. Kyoto Biken Laboratories Company Information Table 136. Kyoto Biken Laboratories Business Overview Table 137. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 138. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio Table 139. Kyoto Biken Laboratories Recent Development Table 140. FATRO Company Information Table 141. FATRO Business Overview Table 142. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 143. FATRO Veterinary Vaccine Product Portfolio Table 144. FATRO Recent Development Table 145. Vaksindo Company Information Table 146. Vaksindo Business Overview Table 147. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 148. Vaksindo Veterinary Vaccine Product Portfolio Table 149. Vaksindo Recent Development Table 150. Bio-Labs Company Information Table 151. Bio-Labs Business Overview Table 152. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 153. Bio-Labs Veterinary Vaccine Product Portfolio Table 154. Bio-Labs Recent Development Table 155. Avimex Animal Health Company Information Table 156. Avimex Animal Health Business Overview Table 157. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 158. Avimex Animal Health Veterinary Vaccine Product Portfolio Table 159. Avimex Animal Health Recent Development Table 160. MEVAC Company Information Table 161. MEVAC Business Overview Table 162. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 163. MEVAC Veterinary Vaccine Product Portfolio Table 164. MEVAC Recent Development Table 165. Biovac Company Information Table 166. Biovac Business Overview Table 167. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 168. Biovac Veterinary Vaccine Product Portfolio Table 169. Biovac Recent Development Table 170. Atafen Company Information Table 171. Atafen Business Overview Table 172. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 173. Atafen Veterinary Vaccine Product Portfolio Table 174. Atafen Recent Development Table 175. Dyntec Company Information Table 176. Dyntec Business Overview Table 177. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 178. Dyntec Veterinary Vaccine Product Portfolio Table 179. Dyntec Recent Development Table 180. BioTestLab Company Information Table 181. BioTestLab Business Overview Table 182. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 183. BioTestLab Veterinary Vaccine Product Portfolio Table 184. BioTestLab Recent Development Table 185. RVSRI Company Information Table 186. RVSRI Business Overview Table 187. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 188. RVSRI Veterinary Vaccine Product Portfolio Table 189. RVSRI Recent Development Table 190. Medion Company Information Table 191. Medion Business Overview Table 192. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 193. Medion Veterinary Vaccine Product Portfolio Table 194. Medion Recent Development Table 195. North America Veterinary Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 196. North America Veterinary Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 197. North America Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 198. North America Veterinary Vaccine Sales by Type (2027-2032) & (M Doses) Table 199. North America Veterinary Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 200. North America Veterinary Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 201. North America Veterinary Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 202. North America Veterinary Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 203. North America Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 204. North America Veterinary Vaccine Sales by Application (2027-2032) & (M Doses) Table 205. North America Veterinary Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 206. North America Veterinary Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 207. North America Veterinary Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. North America Veterinary Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. North America Veterinary Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. North America Veterinary Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 211. North America Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 212. North America Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 213. North America Veterinary Vaccine Sales Price by Country (2021-2026) & (USD/Doses) Table 214. North America Veterinary Vaccine Sales Price by Country (2027-2032) & (USD/Doses) Table 215. United States Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Canada Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Mexico Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Europe Veterinary Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 219. Europe Veterinary Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 220. Europe Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 221. Europe Veterinary Vaccine Sales by Type (2027-2032) & (M Doses) Table 222. Europe Veterinary Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 223. Europe Veterinary Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 224. Europe Veterinary Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 225. Europe Veterinary Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 226. Europe Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 227. Europe Veterinary Vaccine Sales by Application (2027-2032) & (M Doses) Table 228. Europe Veterinary Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 229. Europe Veterinary Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 230. Europe Veterinary Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. Europe Veterinary Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. Europe Veterinary Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. Europe Veterinary Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 234. Europe Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 235. Europe Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 236. Europe Veterinary Vaccine Sales Price by Country (2021-2026) & (USD/Doses) Table 237. Europe Veterinary Vaccine Sales Price by Country (2027-2032) & (USD/Doses) Table 238. Germany Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 239. France Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 240. U.K. Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 241. Italy Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 242. Russia Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 243. Spain Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 244. Netherlands Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 245. Switzerland Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 246. Sweden Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 247. Poland Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 248. China Veterinary Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 249. China Veterinary Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 250. China Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 251. China Veterinary Vaccine Sales by Type (2027-2032) & (M Doses) Table 252. China Veterinary Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 253. China Veterinary Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 254. China Veterinary Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 255. China Veterinary Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 256. China Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 257. China Veterinary Vaccine Sales by Application (2027-2032) & (M Doses) Table 258. China Veterinary Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 259. China Veterinary Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 260. Asia Veterinary Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 261. Asia Veterinary Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 262. Asia Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 263. Asia Veterinary Vaccine Sales by Type (2027-2032) & (M Doses) Table 264. Asia Veterinary Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 265. Asia Veterinary Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 266. Asia Veterinary Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 267. Asia Veterinary Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 268. Asia Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 269. Asia Veterinary Vaccine Sales by Application (2027-2032) & (M Doses) Table 270. Asia Veterinary Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 271. Asia Veterinary Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 272. Asia Veterinary Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 273. Asia Veterinary Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 274. Asia Veterinary Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 275. Asia Veterinary Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 276. Asia Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 277. Asia Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 278. Asia Veterinary Vaccine Sales Price by Country (2021-2026) & (USD/Doses) Table 279. Asia Veterinary Vaccine Sales Price by Country (2027-2032) & (USD/Doses) Table 280. Japan Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 281. South Korea Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 282. India Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 283. Australia Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 284. Taiwan Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 285. Southeast Asia Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 286. SAMEA Veterinary Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 287. SAMEA Veterinary Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 288. SAMEA Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 289. SAMEA Veterinary Vaccine Sales by Type (2027-2032) & (M Doses) Table 290. SAMEA Veterinary Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 291. SAMEA Veterinary Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 292. SAMEA Veterinary Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 293. SAMEA Veterinary Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 294. SAMEA Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 295. SAMEA Veterinary Vaccine Sales by Application (2027-2032) & (M Doses) Table 296. SAMEA Veterinary Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 297. SAMEA Veterinary Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 298. SAMEA Veterinary Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 299. SAMEA Veterinary Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 300. SAMEA Veterinary Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 301. SAMEA Veterinary Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 302. SAMEA Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 303. SAMEA Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 304. SAMEA Veterinary Vaccine Sales Price by Country (2021-2026) & (USD/Doses) Table 305. SAMEA Veterinary Vaccine Sales Price by Country (2027-2032) & (USD/Doses) Table 306. Brazil Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 307. Argentina Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 308. Chile Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 309. Colombia Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 310. Peru Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 311. Saudi Arabia Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 312. Israel Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 313. UAE Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 314. Turkey Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 315. Iran Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 316. Egypt Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Table 317. Key Raw Materials Table 318. Raw Materials Key Suppliers Table 319. Veterinary Vaccine Distributors List Table 320. Veterinary Vaccine Customers List Table 321. Research Programs/Design for This Report Table 322. Authors List of This Report Table 323. Secondary Sources Table 324. Primary Sources List of Figures Figure 1. Veterinary Vaccine Image Figure 2. Global Veterinary Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Attenuated Vaccines Image Figure 5. Inactivated Vaccines Image Figure 6. Others Image Figure 7. Global Veterinary Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Veterinary Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Livestock Image Figure 10. Swine Image Figure 11. Chicken Image Figure 12. Dog & Cat Image Figure 13. Others Image Figure 14. Global Veterinary Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Figure 16. Global Veterinary Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Veterinary Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Veterinary Vaccine Revenue Market Share by Region (2021-2032) Figure 19. Global Veterinary Vaccine Sales (2021-2032) & (M Doses) Figure 20. Global Veterinary Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 21. Global Veterinary Vaccine Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Veterinary Vaccine Sales YoY (2021-2032) & (M Doses) Figure 23. Europe Veterinary Vaccine Sales YoY (2021-2032) & (M Doses) Figure 24. China Veterinary Vaccine Sales YoY (2021-2032) & (M Doses) Figure 25. Asia (Excluding China) Veterinary Vaccine Sales YoY (2021-2032) & (M Doses) Figure 26. South America, Middle East and Africa Veterinary Vaccine Sales YoY (2021-2032) & (M Doses) Figure 27. Global Veterinary Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Veterinary Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Veterinary Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Veterinary Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Veterinary Vaccine Revenue Market Share by Type (2021-2032) Figure 33. Global Veterinary Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 34. Global Veterinary Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Veterinary Vaccine Sales Market Share by Type (2021-2032) Figure 36. Global Veterinary Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Veterinary Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Veterinary Vaccine Revenue Market Share by Application (2021-2032) Figure 39. Global Veterinary Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 40. Global Veterinary Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Veterinary Vaccine Sales Market Share by Application (2021-2032) Figure 42. North America Veterinary Vaccine Revenue Share by Type (2021-2032) Figure 43. North America Veterinary Vaccine Sales Share by Type (2021-2032) Figure 44. North America Veterinary Vaccine Revenue Share by Application (2021-2032) Figure 45. North America Veterinary Vaccine Sales Share by Application (2021-2032) Figure 46. North America Veterinary Vaccine Revenue Share by Country (2021-2032) Figure 47. North America Veterinary Vaccine Sales Share by Country (2021-2032) Figure 48. Europe Veterinary Vaccine Revenue Share by Type (2021-2032) Figure 49. Europe Veterinary Vaccine Sales Share by Type (2021-2032) Figure 50. Europe Veterinary Vaccine Revenue Share by Application (2021-2032) Figure 51. Europe Veterinary Vaccine Sales Share by Application (2021-2032) Figure 52. Europe Veterinary Vaccine Revenue Share by Country (2021-2032) Figure 53. Europe Veterinary Vaccine Sales Share by Country (2021-2032) Figure 54. China Veterinary Vaccine Revenue Share by Type (2021-2032) Figure 55. China Veterinary Vaccine Sales Share by Type (2021-2032) Figure 56. China Veterinary Vaccine Revenue Share by Application (2021-2032) Figure 57. China Veterinary Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Veterinary Vaccine Revenue Share by Type (2021-2032) Figure 59. Asia Veterinary Vaccine Sales Share by Type (2021-2032) Figure 60. Asia Veterinary Vaccine Revenue Share by Application (2021-2032) Figure 61. Asia Veterinary Vaccine Sales Share by Application (2021-2032) Figure 62. Asia Veterinary Vaccine Revenue Share by Country (2021-2032) Figure 63. Asia Veterinary Vaccine Sales Share by Country (2021-2032) Figure 64. SAMEA Veterinary Vaccine Revenue Share by Type (2021-2032) Figure 65. SAMEA Veterinary Vaccine Sales Share by Type (2021-2032) Figure 66. SAMEA Veterinary Vaccine Revenue Share by Application (2021-2032) Figure 67. SAMEA Veterinary Vaccine Sales Share by Application (2021-2032) Figure 68. SAMEA Veterinary Vaccine Revenue Share by Country (2021-2032) Figure 69. SAMEA Veterinary Vaccine Sales Share by Country (2021-2032) Figure 70. Veterinary Vaccine Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Veterinary Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Others
Applications
  • Livestock
  • Swine
  • Chicken
  • Dog & Cat
  • Others
Companies covered
  • Merck
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • CAHIC
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • WINSUN
  • Elanco
  • Virbac
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • CAVAC
  • Kyoto Biken Laboratories
  • FATRO
  • Vaksindo
  • Bio-Labs
  • Avimex Animal Health
  • MEVAC
  • Biovac
  • Atafen
  • Dyntec
  • BioTestLab
  • RVSRI
  • Medion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Vaccine Market by Type
  3. 1.2.1 Global Veterinary Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live Attenuated Vaccines
  5. 1.2.3 Inactivated Vaccines
  6. 1.2.4 Others
  7. 1.3 Veterinary Vaccine Market by Application
  8. 1.3.1 Global Veterinary Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Livestock
  10. 1.3.3 Swine
  11. 1.3.4 Chicken
  12. 1.3.5 Dog & Cat
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Veterinary Vaccine Market Dynamics
  1. 2.1 Veterinary Vaccine Industry Trends
  2. 2.2 Veterinary Vaccine Industry Drivers
  3. 2.3 Veterinary Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Veterinary Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Veterinary Vaccine Revenue by Region
  3. 3.2.1 Global Veterinary Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Veterinary Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Veterinary Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Veterinary Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Veterinary Vaccine Sales by Region
  9. 3.4.1 Global Veterinary Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Veterinary Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Veterinary Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Veterinary Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Veterinary Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Veterinary Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Veterinary Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Veterinary Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Vaccine Sales by Manufacturers
  6. 4.2.1 Global Veterinary Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Veterinary Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Veterinary Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Veterinary Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Veterinary Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Veterinary Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Veterinary Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Veterinary Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Veterinary Vaccine Tier 1, Tier 2, and Tier 3
5 Veterinary Vaccine Market by Type
  1. 5.1 Global Veterinary Vaccine Revenue by Type
  2. 5.1.1 Global Veterinary Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Veterinary Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Veterinary Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Veterinary Vaccine Sales by Type
  6. 5.2.1 Global Veterinary Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Vaccine Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Veterinary Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Veterinary Vaccine Price by Type
6 Veterinary Vaccine Market by Application
  1. 6.1 Global Veterinary Vaccine Revenue by Application
  2. 6.1.1 Global Veterinary Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Veterinary Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Veterinary Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Veterinary Vaccine Sales by Application
  6. 6.2.1 Global Veterinary Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Veterinary Vaccine Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Veterinary Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Veterinary Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Veterinary Vaccine Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Zoetis
  8. 7.2.1 Zoetis Company Information
  9. 7.2.2 Zoetis Business Overview
  10. 7.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zoetis Veterinary Vaccine Product Portfolio
  12. 7.2.5 Zoetis Recent Developments
  13. 7.3 Boehringer Ingelheim
  14. 7.3.1 Boehringer Ingelheim Company Information
  15. 7.3.2 Boehringer Ingelheim Business Overview
  16. 7.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
  18. 7.3.5 Boehringer Ingelheim Recent Developments
  19. 7.4 Ceva
  20. 7.4.1 Ceva Company Information
  21. 7.4.2 Ceva Business Overview
  22. 7.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ceva Veterinary Vaccine Product Portfolio
  24. 7.4.5 Ceva Recent Developments
  25. 7.5 CAHIC
  26. 7.5.1 CAHIC Company Information
  27. 7.5.2 CAHIC Business Overview
  28. 7.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CAHIC Veterinary Vaccine Product Portfolio
  30. 7.5.5 CAHIC Recent Developments
  31. 7.6 HVRI
  32. 7.6.1 HVRI Company Information
  33. 7.6.2 HVRI Business Overview
  34. 7.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 HVRI Veterinary Vaccine Product Portfolio
  36. 7.6.5 HVRI Recent Developments
  37. 7.7 Ringpu Biology
  38. 7.7.1 Ringpu Biology Company Information
  39. 7.7.2 Ringpu Biology Business Overview
  40. 7.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
  42. 7.7.5 Ringpu Biology Recent Developments
  43. 7.8 Yebio
  44. 7.8.1 Yebio Company Information
  45. 7.8.2 Yebio Business Overview
  46. 7.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Yebio Veterinary Vaccine Product Portfolio
  48. 7.8.5 Yebio Recent Developments
  49. 7.9 DHN
  50. 7.9.1 DHN Company Information
  51. 7.9.2 DHN Business Overview
  52. 7.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 DHN Veterinary Vaccine Product Portfolio
  54. 7.9.5 DHN Recent Developments
  55. 7.10 WINSUN
  56. 7.10.1 WINSUN Company Information
  57. 7.10.2 WINSUN Business Overview
  58. 7.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 WINSUN Veterinary Vaccine Product Portfolio
  60. 7.10.5 WINSUN Recent Developments
  61. 7.11 Elanco
  62. 7.11.1 Elanco Company Information
  63. 7.11.2 Elanco Business Overview
  64. 7.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Elanco Veterinary Vaccine Product Portfolio
  66. 7.11.5 Elanco Recent Developments
  67. 7.12 Virbac
  68. 7.12.1 Virbac Company Information
  69. 7.12.2 Virbac Business Overview
  70. 7.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Virbac Veterinary Vaccine Product Portfolio
  72. 7.12.5 Virbac Recent Developments
  73. 7.13 Jinyu Bio-Technology
  74. 7.13.1 Jinyu Bio-Technology Company Information
  75. 7.13.2 Jinyu Bio-Technology Business Overview
  76. 7.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
  78. 7.13.5 Jinyu Bio-Technology Recent Developments
  79. 7.14 ChengDu Tecbond
  80. 7.14.1 ChengDu Tecbond Company Information
  81. 7.14.2 ChengDu Tecbond Business Overview
  82. 7.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
  84. 7.14.5 ChengDu Tecbond Recent Developments
  85. 7.15 CAVAC
  86. 7.15.1 CAVAC Company Information
  87. 7.15.2 CAVAC Business Overview
  88. 7.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 CAVAC Veterinary Vaccine Product Portfolio
  90. 7.15.5 CAVAC Recent Developments
  91. 7.16 Kyoto Biken Laboratories
  92. 7.16.1 Kyoto Biken Laboratories Company Information
  93. 7.16.2 Kyoto Biken Laboratories Business Overview
  94. 7.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
  96. 7.16.5 Kyoto Biken Laboratories Recent Developments
  97. 7.17 FATRO
  98. 7.17.1 FATRO Company Information
  99. 7.17.2 FATRO Business Overview
  100. 7.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 FATRO Veterinary Vaccine Product Portfolio
  102. 7.17.5 FATRO Recent Developments
  103. 7.18 Vaksindo
  104. 7.18.1 Vaksindo Company Information
  105. 7.18.2 Vaksindo Business Overview
  106. 7.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Vaksindo Veterinary Vaccine Product Portfolio
  108. 7.18.5 Vaksindo Recent Developments
  109. 7.19 Bio-Labs
  110. 7.19.1 Bio-Labs Company Information
  111. 7.19.2 Bio-Labs Business Overview
  112. 7.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
  114. 7.19.5 Bio-Labs Recent Developments
  115. 7.20 Avimex Animal Health
  116. 7.20.1 Avimex Animal Health Company Information
  117. 7.20.2 Avimex Animal Health Business Overview
  118. 7.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
  120. 7.20.5 Avimex Animal Health Recent Developments
  121. 7.21 MEVAC
  122. 7.21.1 MEVAC Company Information
  123. 7.21.2 MEVAC Business Overview
  124. 7.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 MEVAC Veterinary Vaccine Product Portfolio
  126. 7.21.5 MEVAC Recent Developments
  127. 7.22 Biovac
  128. 7.22.1 Biovac Company Information
  129. 7.22.2 Biovac Business Overview
  130. 7.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Biovac Veterinary Vaccine Product Portfolio
  132. 7.22.5 Biovac Recent Developments
  133. 7.23 Atafen
  134. 7.23.1 Atafen Company Information
  135. 7.23.2 Atafen Business Overview
  136. 7.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Atafen Veterinary Vaccine Product Portfolio
  138. 7.23.5 Atafen Recent Developments
  139. 7.24 Dyntec
  140. 7.24.1 Dyntec Company Information
  141. 7.24.2 Dyntec Business Overview
  142. 7.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Dyntec Veterinary Vaccine Product Portfolio
  144. 7.24.5 Dyntec Recent Developments
  145. 7.25 BioTestLab
  146. 7.25.1 BioTestLab Company Information
  147. 7.25.2 BioTestLab Business Overview
  148. 7.25.3 BioTestLab Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 BioTestLab Veterinary Vaccine Product Portfolio
  150. 7.25.5 BioTestLab Recent Developments
  151. 7.26 RVSRI
  152. 7.26.1 RVSRI Company Information
  153. 7.26.2 RVSRI Business Overview
  154. 7.26.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 RVSRI Veterinary Vaccine Product Portfolio
  156. 7.26.5 RVSRI Recent Developments
  157. 7.27 Medion
  158. 7.27.1 Medion Company Information
  159. 7.27.2 Medion Business Overview
  160. 7.27.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 Medion Veterinary Vaccine Product Portfolio
  162. 7.27.5 Medion Recent Developments
8 North America
  1. 8.1 North America Veterinary Vaccine Market Size by Type
  2. 8.1.1 North America Veterinary Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Veterinary Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Veterinary Vaccine Price by Type (2021-2032)
  5. 8.2 North America Veterinary Vaccine Market Size by Application
  6. 8.2.1 North America Veterinary Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Veterinary Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Veterinary Vaccine Price by Application (2021-2032)
  9. 8.3 North America Veterinary Vaccine Market Size by Country
  10. 8.3.1 North America Veterinary Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Veterinary Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Veterinary Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Veterinary Vaccine Market Size by Type
  2. 9.1.1 Europe Veterinary Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Veterinary Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Veterinary Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Veterinary Vaccine Market Size by Application
  6. 9.2.1 Europe Veterinary Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Veterinary Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Veterinary Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Veterinary Vaccine Market Size by Country
  10. 9.3.1 Europe Veterinary Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Veterinary Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Veterinary Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Veterinary Vaccine Market Size by Type
  2. 10.1.1 China Veterinary Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Veterinary Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Veterinary Vaccine Price by Type (2021-2032)
  5. 10.2 China Veterinary Vaccine Market Size by Application
  6. 10.2.1 China Veterinary Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Veterinary Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Veterinary Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Vaccine Market Size by Type
  2. 11.1.1 Asia Veterinary Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Veterinary Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Veterinary Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Veterinary Vaccine Market Size by Application
  6. 11.2.1 Asia Veterinary Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Veterinary Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Veterinary Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Veterinary Vaccine Market Size by Country
  10. 11.3.1 Asia Veterinary Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Veterinary Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Veterinary Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Vaccine Market Size by Type
  2. 12.1.1 SAMEA Veterinary Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Veterinary Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Veterinary Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Veterinary Vaccine Market Size by Application
  6. 12.2.1 SAMEA Veterinary Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Veterinary Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Veterinary Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Veterinary Vaccine Market Size by Country
  10. 12.3.1 SAMEA Veterinary Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Veterinary Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Veterinary Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Veterinary Vaccine Value Chain Analysis
  2. 13.1.1 Veterinary Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Veterinary Vaccine Production Mode & Process
  6. 13.2 Veterinary Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Veterinary Vaccine Distributors
  9. 13.2.3 Veterinary Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst